Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Consolidated Statements of Operations        
Revenues $ 22,660,139 $ 16,046,253 $ 60,504,496 $ 43,455,390
Cost of goods sold 3,464,010 2,504,278 9,282,605 6,697,127
Gross profit 19,196,129 13,541,975 51,221,891 36,758,263
Costs and expenses:        
Sales and marketing 14,653,307 9,466,496 41,148,567 27,515,266
Research and development 3,306,856 1,795,292 7,966,535 4,727,551
General and administrative 6,070,547 3,778,612 16,751,038 10,659,756
Total costs and expenses 24,030,710 15,040,400 65,866,140 42,902,573
Loss from operations (4,834,581) (1,498,425) (14,644,249) (6,144,310)
Other income (expense):        
Investment income 727,115   883,665  
Interest expense 5,964 (577,941) (1,123,861) (1,639,874)
Interest expense — deferred financing costs   (46,110) (81,329) (136,711)
Loss on extinguishment of debt     (2,186,114)  
Other expense (126) (1,603) (15,598) (25,388)
Total other expense 732,953 (625,654) (2,523,237) (1,801,973)
Net Loss $ (4,101,628) $ (2,124,079) $ (17,167,486) $ (7,946,283)
Weighted average common shares outstanding — basic and diluted 38,504,810 33,286,211 36,582,261 33,146,546
Loss per common share — basic and diluted $ (0.11) $ (0.06) $ (0.47) $ (0.24)